Company / Operating Cash Flow
STAAR Surgical Company Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$34.2M
FY2025
5-year range
-$34.2M / $35.7M
FY2021-FY2025
Trend
-317.7%
vs FY2024
Sector context
#146 of 164
Health Care
What the data says
Operating Cash Flow changed -318% YoY in FY2025, a notable deviation from the 9-year average annual change of +214%.
Based on SEC 10-K filings.
-$34M in FY2025.
Declined from $15M to -$34M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 164This company -$34.2M Sector average $1.0B
▼
-103.3% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow decreased 317.7% year-over-year.
- Ranks #146 out of 164 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Negative profit margin: -6.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$34.2M | -317.7% |
| FY2024 | $15.7M | +7.7% |
| FY2023 | $14.6M | -59.1% |
| FY2022 | $35.7M | +38.5% |
| FY2021 | $25.8M | +102.0% |
| FY2020 | $12.8M | -50.5% |
| FY2019 | $25.8M | +2359.0% |
| FY2018 | $1.0M | +148.5% |
| FY2017 | -$2.2M | -306.1% |
| FY2016 | $1.0M | +148.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026